Author:
Sparano Francesco,Cavo Michele,Niscola Pasquale,Caravita Tommaso,Efficace Fabio
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Mols F, Oerlemans S, Vos AH, Koster A, Verelst S, Sonneveld P, van de Poll-Franse LV (2012) Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry. Eur J Haematol 89 (4):311–319. doi:
https://doi.org/10.1111/j.1600-0609.2012.01831.x
2. Schumacher M, Olschewski M, Schulgen G (1991) Assessment of quality of life in clinical trials. Stat Med 10(12):1915–1930
3. US Food and Drug Administration: Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. US Department of Health and Human Services Food and Drug Administration.December 2009.
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf
. Accessed April 29, 2016
4. Kurtin S (2013) Relapsed or relapsed/refractory multiple myeloma. Journal of the Advanced Practitioner in Oncology 4(Suppl. 1):5–14
5. Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Zeldenrust SR, Dingli D, Russell SJ, Lust JA, Greipp PR, Kyle RA, Gertz MA (2008) Improved survival in multiple myeloma and the impact of novel therapies. Blood 111(5):2516–2520.
https://doi.org/10.1182/blood-2007-10-116129
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献